Global Chronic Migraine Treatment Market Research Report 2023

Report ID: 1891858 | Published Date: Oct 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Migraine Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drug Treatment
        1.2.3 Substitution Treatment
    1.3 Market by Application
        1.3.1 Global Chronic Migraine Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Chronic Migraine Treatment Market Perspective (2017-2028)
    2.2 Chronic Migraine Treatment Growth Trends by Region
        2.2.1 Chronic Migraine Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Chronic Migraine Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Chronic Migraine Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Chronic Migraine Treatment Market Dynamics
        2.3.1 Chronic Migraine Treatment Industry Trends
        2.3.2 Chronic Migraine Treatment Market Drivers
        2.3.3 Chronic Migraine Treatment Market Challenges
        2.3.4 Chronic Migraine Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Chronic Migraine Treatment Players by Revenue
        3.1.1 Global Top Chronic Migraine Treatment Players by Revenue (2017-2022)
        3.1.2 Global Chronic Migraine Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Chronic Migraine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Chronic Migraine Treatment Revenue
    3.4 Global Chronic Migraine Treatment Market Concentration Ratio
        3.4.1 Global Chronic Migraine Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Migraine Treatment Revenue in 2021
    3.5 Chronic Migraine Treatment Key Players Head office and Area Served
    3.6 Key Players Chronic Migraine Treatment Product Solution and Service
    3.7 Date of Enter into Chronic Migraine Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Migraine Treatment Breakdown Data by Type
    4.1 Global Chronic Migraine Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Chronic Migraine Treatment Forecasted Market Size by Type (2023-2028)
5 Chronic Migraine Treatment Breakdown Data by Application
    5.1 Global Chronic Migraine Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Chronic Migraine Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Chronic Migraine Treatment Market Size (2017-2028)
    6.2 North America Chronic Migraine Treatment Market Size by Country (2017-2022)
    6.3 North America Chronic Migraine Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Chronic Migraine Treatment Market Size (2017-2028)
    7.2 Europe Chronic Migraine Treatment Market Size by Country (2017-2022)
    7.3 Europe Chronic Migraine Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Chronic Migraine Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Chronic Migraine Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Chronic Migraine Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Chronic Migraine Treatment Market Size (2017-2028)
    9.2 Latin America Chronic Migraine Treatment Market Size by Country (2017-2022)
    9.3 Latin America Chronic Migraine Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Chronic Migraine Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Chronic Migraine Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Chronic Migraine Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Chronic Migraine Treatment Introduction
        11.1.4 Novartis Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Chronic Migraine Treatment Introduction
        11.2.4 Pfizer Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Chronic Migraine Treatment Introduction
        11.3.4 AstraZeneca Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 Allergan
        11.4.1 Allergan Company Detail
        11.4.2 Allergan Business Overview
        11.4.3 Allergan Chronic Migraine Treatment Introduction
        11.4.4 Allergan Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.4.5 Allergan Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Detail
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Chronic Migraine Treatment Introduction
        11.5.4 GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Chronic Migraine Treatment Introduction
        11.6.4 Eli Lilly Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.6.5 Eli Lilly Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Chronic Migraine Treatment Introduction
        11.7.4 Merck Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Johnson&Johnson
        11.8.1 Johnson&Johnson Company Detail
        11.8.2 Johnson&Johnson Business Overview
        11.8.3 Johnson&Johnson Chronic Migraine Treatment Introduction
        11.8.4 Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.8.5 Johnson&Johnson Recent Development
    11.9 Zosano
        11.9.1 Zosano Company Detail
        11.9.2 Zosano Business Overview
        11.9.3 Zosano Chronic Migraine Treatment Introduction
        11.9.4 Zosano Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.9.5 Zosano Recent Development
    11.10 Alder BioPharmaceuticals
        11.10.1 Alder BioPharmaceuticals Company Detail
        11.10.2 Alder BioPharmaceuticals Business Overview
        11.10.3 Alder BioPharmaceuticals Chronic Migraine Treatment Introduction
        11.10.4 Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2017-2022)
        11.10.5 Alder BioPharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Chronic Migraine Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drug Treatment
    Table 3. Key Players of Substitution Treatment
    Table 4. Global Chronic Migraine Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Chronic Migraine Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Chronic Migraine Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Chronic Migraine Treatment Market Share by Region (2017-2022)
    Table 8. Global Chronic Migraine Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Chronic Migraine Treatment Market Share by Region (2023-2028)
    Table 10. Chronic Migraine Treatment Market Trends
    Table 11. Chronic Migraine Treatment Market Drivers
    Table 12. Chronic Migraine Treatment Market Challenges
    Table 13. Chronic Migraine Treatment Market Restraints
    Table 14. Global Chronic Migraine Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Chronic Migraine Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Migraine Treatment as of 2021)
    Table 17. Ranking of Global Top Chronic Migraine Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Chronic Migraine Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chronic Migraine Treatment Product Solution and Service
    Table 21. Date of Enter into Chronic Migraine Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chronic Migraine Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Chronic Migraine Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Chronic Migraine Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Chronic Migraine Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Chronic Migraine Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Chronic Migraine Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Chronic Migraine Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Chronic Migraine Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Chronic Migraine Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Chronic Migraine Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Chronic Migraine Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Chronic Migraine Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Chronic Migraine Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Chronic Migraine Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Chronic Migraine Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Chronic Migraine Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Chronic Migraine Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Chronic Migraine Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Novartis Company Detail
    Table 42. Novartis Business Overview
    Table 43. Novartis Chronic Migraine Treatment Product
    Table 44. Novartis Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 45. Novartis Recent Development
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Chronic Migraine Treatment Product
    Table 49. Pfizer Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. AstraZeneca Company Detail
    Table 52. AstraZeneca Business Overview
    Table 53. AstraZeneca Chronic Migraine Treatment Product
    Table 54. AstraZeneca Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 55. AstraZeneca Recent Development
    Table 56. Allergan Company Detail
    Table 57. Allergan Business Overview
    Table 58. Allergan Chronic Migraine Treatment Product
    Table 59. Allergan Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 60. Allergan Recent Development
    Table 61. GlaxoSmithKline Company Detail
    Table 62. GlaxoSmithKline Business Overview
    Table 63. GlaxoSmithKline Chronic Migraine Treatment Product
    Table 64. GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 65. GlaxoSmithKline Recent Development
    Table 66. Eli Lilly Company Detail
    Table 67. Eli Lilly Business Overview
    Table 68. Eli Lilly Chronic Migraine Treatment Product
    Table 69. Eli Lilly Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 70. Eli Lilly Recent Development
    Table 71. Merck Company Detail
    Table 72. Merck Business Overview
    Table 73. Merck Chronic Migraine Treatment Product
    Table 74. Merck Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 75. Merck Recent Development
    Table 76. Johnson&Johnson Company Detail
    Table 77. Johnson&Johnson Business Overview
    Table 78. Johnson&Johnson Chronic Migraine Treatment Product
    Table 79. Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 80. Johnson&Johnson Recent Development
    Table 81. Zosano Company Detail
    Table 82. Zosano Business Overview
    Table 83. Zosano Chronic Migraine Treatment Product
    Table 84. Zosano Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 85. Zosano Recent Development
    Table 86. Alder BioPharmaceuticals Company Detail
    Table 87. Alder BioPharmaceuticals Business Overview
    Table 88. Alder BioPharmaceuticals Chronic Migraine Treatment Product
    Table 89. Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2017-2022) & (US$ Million)
    Table 90. Alder BioPharmaceuticals Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Migraine Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Drug Treatment Features
    Figure 3. Substitution Treatment Features
    Figure 4. Global Chronic Migraine Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Chronic Migraine Treatment Report Years Considered
    Figure 9. Global Chronic Migraine Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Chronic Migraine Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Chronic Migraine Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Chronic Migraine Treatment Market Share by Players in 2021
    Figure 13. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Migraine Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Chronic Migraine Treatment Revenue in 2021
    Figure 15. North America Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Chronic Migraine Treatment Market Share by Country (2017-2028)
    Figure 17. United States Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Chronic Migraine Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Chronic Migraine Treatment Market Share by Region (2017-2028)
    Figure 29. China Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Chronic Migraine Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Chronic Migraine Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Chronic Migraine Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Novartis Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 44. Pfizer Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 45. AstraZeneca Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 46. Allergan Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 48. Eli Lilly Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 50. Johnson&Johnson Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 51. Zosano Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 52. Alder BioPharmaceuticals Revenue Growth Rate in Chronic Migraine Treatment Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
AstraZeneca
Allergan
GlaxoSmithKline
Eli Lilly
Merck
Johnson&Johnson
Zosano
Alder BioPharmaceuticals
Frequently Asked Questions
Chronic Migraine Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Migraine Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Migraine Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bone Density Testing

Bone Density Testing market is segmented by players, region (country), by Type and by Application ... Read More

Cardiac Cannula

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More